2014年5月15日,泰国药理学会前理事长、泰国东方大学Mayuree Tantisira教授一行五人到中国药理学会和中国医学科学院药物研究所进行访问,受中国药理学会理事长杜冠华教授委托,办公室主任穆鑫博士、秘书赵颖博士接待了Mayuree Tantisira教授一行。
中国药理学会常务理事、中国医学科学院药物研究所所长蒋建东教授首先致辞,对泰国来宾表示热烈欢迎。接下来,药物所外事办张莉副主任代表药物所,向来宾介绍了药物所概况和科研情况。Tantisira教授代表泰方,介绍了泰国东方大学和泰国药理学会。赵颖博士代表中国药理学会办公室,介绍了中国药理学会概况,双方学会互赠礼品留念。学会理事长杜冠华还特别委托学会办公室转赠Tantisira教授一本其主编的新书,并表达希望与泰国药理学会加强联系、促进合作的愿望。会谈结束后,泰国来宾参观了药物所分析室、国家药物筛选中心以及中国药理学会办公室,并在中药所和药理学会人员陪同下游览了天坛。
泰国药理学会代表的来访,为今后两国药理学家的深入交流和合作,奠定了良好的基础。
Representatives from Pharmacological and Therapeutic Society of Thailand visited Chinese Pharmacological Society
Five representatives from Thailand, including the past president of Pharmacological and Therapeutic Society of Thailand (PTST), Professor of Burapha University, Ms Mayuree Tantisira, visited Chinese Pharmacological Society (CNPHARS) and Institute of Materia Medica (IMM), CAMS on May 15th, 2014. Dr. Xin Mu, the director of CNPHARS Office, and Dr. Ying Zhao, the secretary of CNPHARS Office, accepted Professor Tantisira’s group on behalf of Professor Guanhua Du, the president of CNPHARS.
Professor Jiandong Jiang, the executive director of CNPHARS, the director of IMM, firstly gave the welcome speech to Thai friends. Dr. Li Zhang, the vice-director of Foreign Affairs Office, IMM, briefly introduced IMM, and Professor Tantisira introduced PTST and the Burapha University. Dr. Ying Zhao introduced CNPHARS to Thai friends and the two societies gave presents to each other. CNPHARS office also forwarded a new book edited by Professor Guanhua Du to Professor Mayuree Tantisira, and conveyed Professor Du’s desire to strengthen association and promote cooperation with PTST. After the talks, Thai guests visited the Department of Pharmaceutical Analysis, National Center for Pharmaceutical Screening, and the office of CNPHARS in IMM, and then visited the Temple of Heaven led by CNPHARS staff member.
The successful visit of Thai representatives would establish a good foundation for the deep communication and cooperation between the pharmacologists from China and Thailand in the future.